In the United States, the FDA is actively warning to stem cell clinic, for example; https://www.fda.gov/consumers/consumer-updates/fda-warns-about-stem-cell-therapies
However, many stemcell clinics are still open for business. As far as I know, any FDA's warning does not include a statement to prohibit the stem cell clinics.
How do American stemcell clinics legally justify themselves?
Although not a US domestic law, the 2013 Declaration of Helsinki contains the following language
Unproven Interventions in Clinical Practice
37. In the treatment of an individual patient, where proven interventions do not exist or other known interventions have been ineffective, the physician, after seeking expert advice, with informed consent from the patient or a legally authorised representative, may use an unproven intervention if in the physician's judgement it offers hope of saving life, re-establishing health or alleviating suffering. This intervention should subsequently be made the object of research, designed to evaluate its safety and efficacy. In all cases, new information must be recorded and, where appropriate, made publicly available.
In other words, my question is.
If you want to legally run a stem cell clinic in the US, what advice would a legal practitioner give you? However, if the regenerative medicine is to be performed that is not approved by the FDA.
At the very least, I think the advice would come that a qualified doctor should treat the patient. What else could it be?
I think the question converges on whether or not the doctor's authority includes the power to "practice medicine with unapproved drugs".
In Japan, stem cell clinics can justify themselves by undergoing a review under the Safety Assurance Act. Details are given below. In the past, there was no such scheme, but it seems to have used the logic that "doctors can perform unapproved therapeutic acts at the request of their patients". How does this work in the US?
In Japan, most of stemcell clinics get the legal justification using the Act on the Safety of Regenerative Medicine. Class 2 or class 3 regenerative medicine can be provided to patients as long as it is reviewed by the "Certified Special Committee for Regenerative Medicine", regardless of the result of the review; class 2 and class 3 are classified by the Act on the Safety of Regenerative Medicine. These classes includes most of autologous transplantation of the stem cells.
For the legal framework of regenerative medicine in Japan, the following will be helpful.
I asked this question first in the medical stack, but was advised that the legal stack was preferable, so I decided to ask the same question here.